Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice

Background: Quinolone-containing triple therapy is recommended as an option for non-bismuth containing second-line Helicobacter pylori eradication. Current available Taiwanese reports in the literature used 7-day quinolone-containing triple therapy. As a result, some physicians still prescribe 7-day...

Description complète

Détails bibliographiques

Auteurs principaux:	Chih-Ming Liang, Jen-Wen Cheng, Chung-Mou Kuo, Kuo-Chin Chang, Keng-Liang Wu, Wei-Chen Tai, King-Wah Chiu, Shue-Shian Chiou, Ming-Tsung Lin, Tsung-Hui Hu, Seng-Kee Chuah
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2014-10-01
Collection:	Biomedical Journal
Sujets:	7-day levofloxacin-containing triple therapy fluoroquinolone second-line anti-Helicobacter pylori therapy
Accès en ligne:	http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=5;spage=326;epage=330;aulast=Liang
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!